SECTIONS
ET APPS
ET TV
LATEST NEWS
- SC dismisses plea of district judge against swearing-in of Karnataka HC judge
- JK govt declares entire Kashmir valley, 2 district of Jammu in red zone
- Bengal to decide on lockdown relaxations in green, orange zones
- DHS report: China hid virus' severity to hoard supplies
- When will PM Johnson send Britain back to work?
- State units will work out modalities with Railways, chief secys to pay train fare of migrants: Congress
- View: Coronavirus is straining the concept of federalism
- Challenges confronting world due to COVID-19 put forth global governance inadequacies: Akbaruddin
- India lodges protest with Islamabad over Pakistan court's order on Gilgit-Baltistan
Business News›News›ET TV›COVID-19 vaccine: Safety trial of 'Mycobacterial w' drug completed, says PGIMER Director, Chandigarh
COVID-19 vaccine: Safety trial of 'Mycobacterial w' drug completed, says PGIMER Director, Chandigarh
Post Graduate Institute of Medical Education and Research (PGIMER) Director Dr Jagat Ram informed that the trial of Mycobacterium w (Mw) drug has been completed. “The safety trial of 'Mw vaccine' drug has been completed. But its actual trial will be conducted on 40 patients at PGI Chandigarh, AIIMS-Delhi and AIIMS-Bhopal,” said Dr Ram.
Related Videos
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service